Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 401–450 of 537 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02435186	p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer	unknown	Phase 2	100	Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY	1	May 6, 2015	clinicaltrials
NCT00949455	A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium(LaMB)	unknown	Phase 2 / Phase 3	204	Queen Mary University of LondonOTHER	1	Apr 15, 2015